iKnowMed EHR and iKnowMed Generation 2 EHR Receive 2015 ONC-ACB Certification

January 05, 2018

Providers using iKnowMed certified EHR technology are eligible for Quality Performance bonus points under Merit-based Incentive Payment System

The Woodlands, Texas (January 5, 2018) — McKesson Specialty Health, an industry leader in services and technologies that advance community-based healthcare, announced that iKnowMedSM electronic health record (EHR) (version 6.8) and iKnowMed Generation 2 EHR (version 3.0) have received ONC-ACB 2015 Edition Certification. These products, with the support of My Care PlusSM patient portal (version 3.13) and Practice InsightsSM analytics (version 1.5), were certified as “Meaningful Use-ready” to support practices participating in value-based care. In addition to the many clinical and operational benefits these technologies bring to practices, providers using iKnowMed are eligible for bonus points in the Quality Performance category under the Merit-based Incentive Payment System (MIPS).

The products were tested and certified through the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program and are now certified as 2015 Edition compliant. Practices utilizing iKnowMed can demonstrate Meaningful Use in 2015, helping them avoid penalties under the American Recovery and Reinvestment Act while making them eligible for incentive payments under MIPS.

Combining the advanced technologies of McKesson Specialty Health with expertise from physicians in The US Oncology Network, these leading-edge technology products provide unique support for practices, enabling them to efficiently respond to the ever-changing requirements of the value-based environment while delivering high-quality care to patients. The products incorporate the latest interoperability standards, facilitating seamless exchange of patient information with other electronic systems, including EHRs at collaborating practices and hospitals.

“Our 2015 Edition certified products are leading the way in value-based care solutions, providing efficient technologies that drive better care and care coordination, support improved clinical and business decisions, and enhance patient engagement,” said Dan Lodder, vice president and general manager, Technology Solutions, McKesson Specialty Health. “Additionally, practices using iKnowMed are eligible to collect incentive dollars by attesting to Meaningful Use in 2015 and beyond, contributing to the financial success of the practice.”

The iKnowMed EHR team is committed to providing superior service and support for community-based providers, enabling practices to quickly and efficiently implement new technologies to meet Meaningful Use requirements while maximizing incentives available through MIPS. In 2015 and 2016, more than 90% of practices using iKnowMed in both The US Oncology Network and McKesson’s Onmark Select Program were successful in attesting to Meaningful Use. This provided $6.9 million in iKnowMed incentive payments to affiliated practices in 2015 and 2016.

“Maintaining compliance in today’s dynamic regulatory landscape is increasingly challenging for community-based oncology practices,” said Marcus Neubauer, M.D., vice president and medical director, Payer and Clinical Services, McKesson Specialty Health. “McKesson’s Meaningful Use certified technologies play a vital role in enabling practices to keep up to date with the changing healthcare landscape, allowing them to efficiently and successfully implement the changes that are vital to succeed in value-based care.”

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, passionately driven by the benefits it provides patients and the system as a whole. Through innovative provider, practice management, biopharma and payer solutions, McKesson Specialty Health focuses on improving the financial, operational and business health of our customers and partners so they may provide the best care to patients. At McKesson Specialty Health, we believe that we are all in this together. For more information, visit www.McKessonspecialtyhealth.com.

About The US Oncology Network

Every day, The US Oncology Network helps more than 1,400 independent physicians deliver value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides doctors with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Specialty Health. This collaboration allows the doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Together, The Network and its affiliated physicians are committed to the success of independent practices, everywhere. For more information, visit www.usoncology.com.

Public Relations Contact